Actively Recruiting
Cervical Cancer Susceptible Population Classification
Led by Anhui Provincial Hospital · Updated on 2024-05-09
10000
Participants Needed
1
Research Sites
630 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cervical cancer is the third most common lethal tumor globally, causing around a quarter million deaths annually, despite the availability of HPV vaccines. Recent Genome-wide association studies (GWAS) have identified numerous genetic markers linked to cervical cancer, including rs10175462, rs10007915, rs35721900, and rs61646675, which have been verified as being related to susceptibility to cervical cancer. However, many reports lack clarity, consistency, and validation. In this comprehensive study, we will analyze the genomic risk factors associated with cervical cancer, classify individuals into different risk categories, and explore potential biomarkers and therapeutics.
CONDITIONS
Official Title
Cervical Cancer Susceptible Population Classification
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects aged 18 years or older at the time of consent
- Planning to undergo screening colposcopy
- Considered by a doctor or healthcare provider to have average risk for cervical cancer
- Willing to consent to blood draws for cervical disease tests
- Willing to agree to follow-up visits for five years as outlined in the study protocol
You will not qualify if you...
- History of cervical cancer
- History of any cancer except skin squamous cell cancer removed at least 12 months before consent
- Currently taking any anti-cancer or disease-modifying anti-rheumatic drugs
- Experienced major physical trauma such as surgery, organ transplant, or blood transfusion within 30 days before consent
- Any medical condition that the investigator believes should prevent participation in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital of USTC
Hefei, Anhui, China, 230001
Actively Recruiting
Research Team
Y
Yingying Wang, Doctor
CONTACT
T
Tingting Zhao, Master
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here